Device Trial Radar · NCT02772354
Radiofrequency Ablation of Symptomatic Frequent Ventricular Premature Complexes in Pediatric Population
Last checked: Nov 20, 2026Latest source record: Sep 9, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
124
Planned (sponsor's estimate)
Start
Apr 2016
Primary completion
Sep 2017
Study completion Apr 2018
Sponsor
- Lead sponsor
- Meshalkin Research Institute of Pathology of CirculationResearch network
- Sponsor type
- Research network
- First posted
- May 13, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 7 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the effectiveness and safety of catheter ablation of frequent symptomatic PVCs in the pediatric population as first-line therapy compared with antiarrhythmic drugs.
Conditions
- Ventricular Arrhythmia
Interventions
Radiofrequency catheter ablationProcedure
Biosense Webster: NAVI-STAR ThermoCool, NAVI-STAR® RMT ThermoCool
MetoprololDrug
Antiarrhythmic therapy of premature ventricular complexes Metoprolol 12-50 mg
VerapamilDrug
Verapamil 20-240 mg
NAVI-STAR® RMT ThermoCoolDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- The presence of premature ventricular complexes ≥ 300 according to the 24-hour Holter ECG monitoringTime frame: 12 months
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Research Clinical Institute of Pediatrics, N.I. Pirogov Russian National Research Medical University
Moscow, Russia · Recruiting
State Research Institute of CIrculation Pathology Novosibirsk, Russian Federation
Novosibirsk, Russia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.